| Application no. and date | 06820997.2 (espacenet) (Federated) (European Patent Register), 20061123 | | Patent/reg. no. and date | DK/EP 1959955, 20101117 | | Publication date | 20080827 | | Priority no. and date | US 742766 P, 20051205, US 864637 P, 20061107 | | EP pub. no. and date |
EP 1959955 20080827 | | Effective date | | | Applicant/owner | Pfizer Products Inc., Eastern Point Road
Groton, CT 06340, US | | Applicant ref. no. | P81007950DK00E | | Inventor | CHRISTENSEN, James Gail, Agouron Pharmaceuticals Inc.
A Pfizer Company
10555 Science Center Drive
San Diego, CA 92121, US,
ZOU, Yahong, Agouron Pharmaceuticals Inc.
A Pfizer Company
10555 Science Center Drive
San Diego, CA 92121, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/4545 (2006.01) , A61P 35/00 (2006.01) | | Title | Fremgangsmåde til behandling af abnorm cellevækst | | Int. application no. | IB2006003397 | | Int. publication no. | WO2007066187 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
